Jay M. Moyes, a director, made two open market purchases of Sintx Technologies ($SINT) shares in the last year, totaling $13,666, with the most recent on February 23, 2026. These rank 4,097th among 4,983 insiders, well below the average purchase of 1.5 million across 3.29 transactions. He also sold Puma Biotechnology ($PBYI) shares once for $74,800 on June 13, 2025, ranking 9,957th out of 11,678 sellers with an average of 8.6 million over 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Sintx Technologies, Inc. | $SINT | MOYES JAY M | Director | P | Common Stock | 1000 | $2.91 | 4,000.0000 | 3,851,956 | 33.33% | 0.03% |
| Dec. 8, 2025 | BioCardia, Inc. | $BCDA | MOYES JAY M | Director | A | Stock Option (right to buy) | 12000 | $0.00 | 15,573.0000 | 10,612,734 | 335.85% | 0.11% |
| Aug. 26, 2025 | Sintx Technologies, Inc. | $SINT | MOYES JAY M | Director | P | Common Stock | 3000 | $3.59 | 3,000.0000 | 2,515,179 | 9999.99% | 0.12% |
| June 13, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | S | Common Stock | 22000 | $3.40 | 53,322.0000 | 49,100,433 | 29.21% | 0.04% |
| June 11, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | A | Common Stock | 27000 | $0.00 | 75,322.0000 | 49,100,433 | 55.88% | 0.05% |
| Oct. 11, 2024 | BioCardia, Inc. | $BCDA | MOYES JAY M | Director | A | Stock Option (right to buy) | 829 | $0.00 | 3,573.0000 | 0 | 30.21% | 0.00% |
| June 18, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | A | Common Stock | 27000 | $0.00 | 48,322.0000 | 47,550,852 | 126.63% | 0.06% |
| June 13, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | S | Common Stock | 22000 | $3.34 | 21,322.0000 | 47,550,852 | 50.78% | 0.05% |
| Oct. 18, 2023 | BioCardia, Inc. | $BCDA | MOYES JAY M | Director | A | Stock Option (right to buy) | 12434 | $0.00 | 41,233.0000 | 0 | 43.18% | 0.00% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | S | Common Stock | 22000 | $3.45 | 16,322.0000 | 44,929,998 | 57.41% | 0.05% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MOYES JAY M | Director | A | Common Stock | 27000 | $0.00 | 43,322.0000 | 44,929,998 | 165.42% | 0.06% |
| March 6, 2023 | SERA PROGNOSTICS, INC. | $SERA | MOYES JAY M | Chief Financial Officer | A | Class A Common Stock | 32800 | $0.00 | 35,630.0000 | 0 | 1159.01% | 0.00% |
| March 6, 2023 | SERA PROGNOSTICS, INC. | $SERA | MOYES JAY M | Chief Financial Officer | A | Stock Option (right to buy) | 51800 | $0.00 | 51,800.0000 | 0 | 9999.99% | 0.00% |